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FACTORS INFLUENCING HAART ADHERENCE AMONG PRIVATE HEALTH CARE 
SECTOR PATIENTS IN A SUBURB OF THE ETHEKWINI METRO
ABsTRAcT
Background: The advent of highly active antiretroviral therapy (HAART) ushered in a new era in 
the management of the AIDS pandemic with new drugs, new strategies, new vigour from treating 
clinicians and enthusiasm on the part of their patients. What soon became evident, however, was the 
vital importance of patient adherence to prescribed medication in order to obtain full therapeutic 
benefi ts. Several factors can infl uence adherence to HIV drug regimens. Many treatment regimes are 
complex, requiring patients to take a number of drugs at set times during the day, some on a full 
stomach and others on an empty one. Other factors that could contribute to non-adherence include: 
forgetting to take medications, cost factor, side effects, incorrect use of drug, social reasons, denial or 
poor knowledge of drug regime. If the correct regimen is not prescribed and if patients do not adhere 
to therapy, then the possibility of resistant strains is high. Improving adherence is therefore arguably 
the single most important means of optimising overall therapeutic outcomes. Although several studies 
regarding patient adherence have been performed in the public health care sector, data on adherence 
in patients from the private health care sector of South Africa remain limited. Many factors infl uence 
compliance and identifying these factors may assist in the design of strategies to enhance adherence to 
such demanding regimens. This study aimed to identify these factors among private sector patients.
 
Method: Descriptive cross-sectional study was conducted among all consenting patients with HIV who 
visited the rooms of participating private sector doctors from May to July 2005. A questionnaire was 
administered to consenting participants. Participants who reported missing any medication on any day 
were considered non-adherent. The data obtained was analysed using SPSS 11.5. A probability value of 
5% or less was regarded as being statistically signifi cant. Categorical data was described using frequency 
tables and bar charts. Pearson’s chi-square tests or Fischer’s exact tests were used interchangeably as 
appropriate to assess associations between categorical variables. The study received ethics approval 
from the University of KwaZulu-Natal’s Nelson R Mandela School of Medicine Ethics Committee. 
Results: A total of 55 patients completed the questionnaires and 10 patients refused to participate. There 
was no statistical difference between adherence to treatment and demographics such as age, gender 
and marital status. In this study 89.1% of patients were classifi ed as non-adherent and reasons for non-
adherence included diffi culty in swallowing medicines (67.3%) (p = 0.01); side effects (61.8%) (p = 0.03); 
forgetting to take medication (58.2%) (p = 0.003); and not wanting to reveal their HIV status (41.8%) 
(p = 0.03). Common side effects experienced were nausea, dizziness, insomnia, tiredness or weakness. 
Reasons for taking their medicines included tablets would save their lives (83.6%); understand how 
to take the medication (81.8%); tablets would help them feel better (80.0%); and were educated about 
their illness (78.2%). The majority of participants (65.5%) were on two nucleoside reverse transcriptase 
inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI). All participants that 
were on a regimen that comprised protease inhibitors and two NRTIs were found to be non-adherent.
Conclusion: Some barriers to adherence among this cohort of private sector patients are similar to those 
experienced by public sector patients. It will be important for doctors to identify these problems and 
implement strategies that could improve adherence, e.g. using short message services (SMSs) reminders 
for those patients prone to forgetting to take their medicines, breaking the tablets into smaller pieces 
in order to overcome the diffi culty of swallowing, if the medication is not available in a liquid form, 
looking at alternative medication with lesser or more tolerant side effect profi les and greater counselling 
on the drugs. 
 inTRODucTiOn
On a global scale, the number of people living with HIV in 2007 was 33.2 million, a reduction of 16% 
compared with the estimate published in 2006 (39.5 million). In sub-Saharan Africa an estimated 22.5 
million adults and children are living with HIV and AIDS. Sub-Saharan Africa remains the most seriously 
affected region, with AIDS the leading cause of death.1
The advent of highly active antiretroviral therapy (HAART) ushered in a new era in the management of 
patients with AIDS. What soon became evident, however, was the vital importance of patient adherence 
to prescribed medication in order to obtain full therapeutic benefi ts.2 Adherence to antiretroviral therapy 
(ART) is a crucial determinant of treatment success. While the ultimate goal of ART is to reduce HIV-
related morbidity and mortality, the initial goal is full and durable viral suppression. For most patients, 
near-perfect (> 95%) adherence is necessary to achieve full and durable viral suppression. In practice, 
this degree of adherence requires a patient on a twice-daily regimen not to miss or substantially delay 
more than three doses of antiretroviral medications per month.3 Many factors infl uence compliance and 
identifying these factors may assist in the design of strategies to enhance adherence to such demanding 
regimens.4 
Many treatment regimes are complex and require patients to take a number of drugs at set times during 
the day, some on a full stomach and others on an empty one. For people who endure tremendous fi nancial 
hardship and who are unable to work or eat regular meals, the situation is even more challenging. The 
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authors in a study carried out in Cape Town, South Africa, 
concluded that socioeconomic status had no impact on adherence, 
and that patients with very little or no financial means can have 
successful treatment outcomes when the financial barriers 
to treatment are removed. However, the number of times the 
medicines were taken was a strong predictor for poor adherence 
and virological failure.5 In another study carried out in a public 
sector hospital in Soweto, South Africa, the main reasons cited 
for missing doses among patients were being away from home 
(30%), difficulty with the dosing schedules (23%), and  running 
out of tablets (12%). Adherence decreased considerably with 
fear of being stigmatized by the sexual partner (OR = 0.13 95%, 
CI 0.02-0.70). 6 
If barriers that impede medication adherence go unrecognised 
and unresolved, the management of HIV and AIDS patients 
would be compromised with disastrous results in terms of 
resistance emerging. Resistance to antiretroviral drugs is a 
concern in the treatment of HIV and AIDS, because once it 
occurs, it affects patients’ clinical outcome and also reduce 
patients’ treatment options. While this is clearly a bad situation 
for the individual, from a public health perspective it is also 
alarming to have multiple drug-resistant strains of HIV that can 
be transmitted to non-infected people.7 Improving adherence is 
therefore arguably the single most important means of optimising 
overall therapeutic outcomes. A study carried out among primary 
care public sector patients in South Africa demonstrated that 
with a standard approach of preparing patients and strategies to 
enhance adherence, patients on antiretroviral medication can be 
retained in a resource-limited setting.8  
Although studies have been carried out to establish the extent 
of adherence in public sector patients, there is limited adherence 
data from patients in the private health care sector of South 
Africa, particularly in KwaZulu-Natal – the province with 
the highest HIV and AIDS prevalence rates. Furthermore, in 
anecdotal reports from private sector doctors there was an 
indication that many of their patients are non-adherent. They 
maintain that they follow the guidelines prescribed for optimum 
care of these patients but the desired therapeutic outcome is not 
evident in the majority of their patients. Therefore, based on the 
knowledge that ART has been available in the private health 
care sector since 1996, it was decided that a study be conducted 
among patients visiting private sector doctors to identify factors 
that influence adherence to ART. 
METHOD
Study design
A cross-sectional, descriptive study was conducted.
Sampling
Doctors working within a 2 km radius of an area to the south of 
the Ethekwini region of KwaZulu-Natal were asked to participate 
in the study. These doctors had to be managing HIV and AIDS 
patients. The doctors were practicing in an area that saw South 
African patients from both African and Indian origin, whose 
socioeconomic status ranged from very poor to very wealthy. 
Some lived in formal housing and others in informal housing. 
The study was conducted in a private and enclosed area of each 
of the medical practices selected.
The sampling frame included all consenting patients with 
HIV and AIDS visiting the selected medical practices during 
the research period, identified as the months of May to July 
2005. In addition, to be eligible, patients had to be on ART. An 
appointment register was available to the researchers on the day 
of the study. The HIV and AIDS patients who were receiving 
treatment and who were visiting the practices on that specific day 
were highlighted in the register by the doctor. The researchers 
made contact with these patients on their arrival at the doctors’ 
rooms for their appointments and explained the study to them. 
Those patients who were willing to participate and who signed 
a consent form were enrolled in the study.
Study variables and instrument
Previously piloted self-reported questionnaires containing 
both open-ended and closed questions were developed by the 
researchers. These questionnaires, available in English and 
IsiZulu, were administered by the researchers to the participants 
in their preferred language. Medical charts of the participants 
were viewed to confirm the current HIV treatment regimen. 
Participants who reported missing any medication on any day in 
a month were considered non-adherent (95% adherence level). 
The instrument was divided into two sections, namely 
demographics and medicine taking (reasons for not taking 
medication, side effects and perceived positive outcomes with 
respect to whether the medicines were working or not working 
for them). 
Statistical analysis
The data obtained was analysed using SPSS Version 11.5. A 
probability value of 5% or less was regarded as being statistically 
significant. Categorical data was described using frequency 
tables and bar charts. Pearson’s chi-square tests or Fischer’s 
exact tests were used interchangeably as appropriate to assess 
associations between categorical variables. The study received 
ethics approval from the University of KwaZulu-Natal’s Nelson 
R Mandela School of Medicine Ethics Committee. 
REsulTs
Four doctors participated in the study and a total of 55 patients 
were enrolled. Of the 55 patients that participated in the study, 
89.1% were classified as non-adherent.
The majority of participants n = 37 (67%) were female and 83.6% 
of participants were between the ages of 20 to 39 years, of which 
86.9% were non-adherent.
The most common HAART regimens were: regimen one: 
zidovudine, lamivudine and efavirenz (45.5%); regimen two: 
lamivudine, stavudine and efavirenz (20.0%); and regimen three: 
lopinavir, ritonovir, zidovudine and lamivudine (12.7%). The 
majority of participants (65.5%) were on two nucleoside reverse 
transcriptase inhibitors (NRTIs) and one non-nucleoside reverse 
transcriptase inhibitor (NNRTI). All participants on regimen 
three (comprising protease inhibitors (PIs) and two NRTIs), 
were found to be non-adherent.
Reasons for not taking medication
Respondents offered many reasons for not taking their 
medication, with significant findings relating to the difficulty 
experienced in swallowing the medication, side effects of the 
medication, forgetting to take their medication and reasons 
relating to stigma. Interestingly, 9.1% of respondents did not 
take their medicines because they were not part of the decision 
making about their illness with the doctor.   (Table 1).
Side effects
When respondents were asked about whether they experienced 
any side effects, over 55% of respondents reported nausea, 
dizziness and insomnia as side effects with a small percentage 
(1.8%) reporting ketoacidosis and kidney stones as a side effect 
(Table 2).
 
Reasons for taking medication
Figure 1 describes the reasons why participants took their 
medication, with 83.6% stating that they take their medicines 
because the tablets will save their lives and 74.6% being 
influenced by the information provided by their health care 
provider. 
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As a result of their many adverse effects, drug interactions 
and food restrictions,10, 14,15, 16.HAART regimens, especially 
those containing PIs, have been implicated in promoting non-
adherence.  
It is widely known that side effects to ART contribute to non-
adherence and discontinuation of HAART.11,17,18 This study 
demonstrated that 61.8% of participants did not take their 
medication due to side effects, with nausea being the most 
common side effect experienced by participants. This is consistent 
with other studies that show that nausea increases the risk for 
non-adherence regardless of the time the participants were 
on medication.19 Insomnia and dizziness were also commonly 
experienced by participants who were on efavirenz. This is a 
well-documented side effect for people with HIV who are on 
long-term efavirenz therapy20 and on a HAART regimen.19 
This study also found that participants frequently forgot to take 
their medication, which is not unique to this study but has been 
reported previously4,9,11,17 as one of the most common or frequent 
reasons for non-adherence. Reminders such as short message 
services (SMSs) on cell phones, alarm wrist watches or timer 
settings should be encouraged to assist patients in remembering 
to take their medicines on time. 
An interesting finding in this study was the association of 
difficulty in swallowing and being non-adherent. Participants in 
this study experienced difficulty in swallowing their medication 
and were therefore not able to take them. This reason for non-
adherence has not been previously cited and perhaps should 
be looked at seriously when dosage forms are being prescribed 
or dispensed to patients. Pill size was reported as one of the 
attributes that to some degree impacts on adherence.21  
This study also reported consistent findings with other studies22 
in terms of stigmatisation and adherence to therapy in that 
participants did not take their medication because they did not 
want to reveal their HIV status. Therefore, it is important when 
counselling is provided to people with HIV that adherence and 
FIGURE 1
Reasons for taking medication





Difficulty in swallowing medicine 67.3 0.01
Side effects 61.8 0.03
Forgot to take medicine 58.2 0.003
Not reveal HIV status 41.8 0.03
Too many tablets to take 32.7 Not significant
Difficult to take specific times of day 23.6 Not significant
Falling asleep 20 Not significant
Feeling sad 20 Not significant
Too busy 18.2 Not significant
Did not receive medicines from pharmacy 12.7 Not significant
Too many directions to take 10.9 Not significant
Difficulty in acquiring the medicine 10.9 Not significant
Not part of decision making 9.1 Not significant
Ran out of medicine 9.1 Not significant
open-ended responses
Husbands not allowing wives to take 
medication
4.2 Not significant
Felt better therefore stopped taking 
medicines
2.1 Not significant
Had body aches in the morning therefore not 
taking morning dose
2.1 Not significant















Reasons for not taking medication (n = 55)
taBlE 2
Side effects experienced (n = 55)
83.60%
Got information 
from health care 
provider
DiscussiOn
The majority of the participants surveyed in the four participat-
ing medical practices were non-adherent. Some of the reasons 
cited were significant, such as side effects experienced, difficulty 
in swallowing, forgetting to take their medication and stigma. 
The majority of the participants who were between the ages of 
20 to 39 were found to be non-adherent. This finding, though not 
statistically significant, is supported by a presentation and study 
carried out by Valerie Stone, in which it was indicated that the 
younger age (< 35 years) is a patient factor predictive of non-
adherence, and that young females were more non-adherent.9 
Another study also found that moderate and poor adherence 
were independently associated with younger age.10
The most problematic dosage regimen was the one that had 
protease inhibitors (PIs), that is, lopinavir and ritonavir, together 
with zidovudine and lamivudine. The total number of tablets 
taken in this regimen was greater than seven per day and may 
have contributed to participants being non-adherent. Several 
studies have shown that regimen complexity significantly affects 
non-adherence.11,12,13
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disclosure not be separated. Interventions targeted at adherence 
should seek to help the patient to concurrently manage disclosure 
of their seropositivity and its consequences.23 Some of the reasons 
provided by respondents as to why they take their medication 
confirm that when they are educated about their illness, have 
information from their health care provider about their illness 
or medicines, or if they understand how to take their medicines 
patients feel confident to take the medication. However, when 
they were not part of the decision making, some of these patients 
did not take their medication as reported. Barriers to adherence 
such as patient factors, health care providers themselves and the 
health care system need special attention in order to improve 
adherence. Strategies such as educating patients, improving 
communication between patients and health care providers, 
improving dose scheduling, providing drugs with less adverse 
effects and improving accessibility to health care are of paramount 
importance in the battle against non-adherence.24 While patients 
are ultimately responsible for taking their medication, good 
communication, involving the patient in decision making about 
their care and simplifying drug regimens go a long way in 
improving it.24
limitations of the study
The sample size in this study was small and therefore it does 
not allow a general statement to be made about all private sector 
patients in South Africa.  
conclusion and recommendations
The results from this study indicate that adherence to ART is a 
problem among private health care sector patients in KwaZulu-
Natal, and that barriers to adherence do exist. These barriers to 
adherence are similar to those cited by public sector patients. 
The researchers recommend that a larger study, with a bigger 
sample size, be carried out a much wider area. In order to validate 
the authenticity of the participants’ responses, the medical 
charts should be used to confirm whether they are adherent 
or not. The clinical outcomes of the patients may be used as an 
indicator. Reported interventions that improve adherence such 
as pill boxes, SMS reminders, alarms and pill counts should be 
implemented. Dosage forms should be prescribed according to 
individual preferences; however, when not available, breaking 
the tablets carefully into smaller sizes if they are scored should 
be encouraged and counselled on, so that the entire dose is 
taken. 
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